Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-14.82%Earnings Yield
VS
Market
Sector
Industry
History
$ 5.78Close
$ 2.41 - $ 6.65 52-Week Range
Ticker Information
Ticker
EPRXCompany Name
EUPRAXIA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQEUPRAXIA PHARMACEUTICALS INC - Earnings Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
EPRX - Earnings Yield Historical data
| Date | Earnings Yield | Market Capitalization | Net Income Common Stock |
|---|---|---|---|
| 6/30/2025 | -14.82% | $ 195.98M | $ -29.04M |
| 3/31/2025 | -18.11% | $ 145.55M | $ -26.35M |
| 12/31/2024 | -18.47% | $ 139.36M | $ -25.74M |
| 9/30/2024 | -20.03% | $ 112.67M | $ -22.56M |
| 6/30/2024 | -27.16% | $ 85.14M | $ -23.12M |
| 3/31/2024 | 0% | $ 103.31M | $ 0 |
| 12/31/2023 | 0% | $ 0 | $ -28.97M |
Key Performance Insights, Last 5 Years
- EUPRAXIA PHARMACEUTICALS INC's latest trailing twelve months (TTM) Earnings Yield stands at 0%.
- Over the past 5 years, EUPRAXIA PHARMACEUTICALS INC's average Earnings Yield has been -19.72%.
- The median Earnings Yield for EUPRAXIA PHARMACEUTICALS INC during this period was -18.47%
- EUPRAXIA PHARMACEUTICALS INC reached its highest Earnings Yield over the past 5 years at -14.82%.
- The lowest Earnings Yield recorded by EUPRAXIA PHARMACEUTICALS INC in the same timeframe -27.16%
Similar metrics to Net Inc. Cmn.:
- Price to Earnings - [Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
Definition of Earnings Yield
[Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].Net Inc. Cmn. / Market Cap
(=) Earnings Yield Earnings Yield for EUPRAXIA PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ -28.97M ] / Market Cap [ $ 0 ]
(=) Earnings Yield [ 0% ] EPRX - Earnings Yield, Last 5 years
-27.16%
Minimum
Jun 30, 2024
-14.82%
Maximum
Jun 30, 2025
-19.72%
Average
-18.47%
Median
Earnings Yield Benchmark AnalysisMarket
The chart above depicts the distribution of Earnings Yield for companies in the Total Stock Market. The average Earnings Yield of the companies is 0.33% with a standard deviation of 9.82%.
The following table provides additional summary stats:
Earnings Yield in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | -31.79% |
| max | 32.87% |
| average | 0.33% |
| median | 2.78% |
| std | 9.82% |